Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
383.00    2.00 (0.52%)
Bid:
378.00
Ask:
384.50
Spread: 6.50 (1.72%)
Market Cap: £1.96b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

8 Jan 2019 15:40

RNS Number : 5327M
Caledonia Investments PLC
08 January 2019
 

Caledonia Investments plc

Director/PDMR Shareholding Notification

 

Caledonia Investments plc ("Caledonia") has been notified pursuant to the requirements of the EU Market Abuse Regulation of the following transactions involving two of its directors, Jamie Cayzer-Colvin and William Wyatt, as detailed below.

 

On 8 January 2019, ordinary 5p shares were transferred to the above-named directors under Caledonia's 2011 Performance Share Scheme ("Performance Share Scheme") and Caledonia's 2011 Deferred Bonus Plan ("Deferred Bonus Plan") at nil cost. All shares were sourced from the Caledonia Investments plc Employee Share Trust ("EST") and subsequently sold back to the EST at 2907.5p per share on the same date.

 

 

No of shares transferred under the Performance Share Scheme at £nil

 

No of shares transferred under the Deferred Bonus Plan at £nil

 

No of shares sold

% of issued capital

JMB Cayzer-Colvin

 

14,358

10,670

25,028

0.05

WP Wyatt

 

23,352

17,784

41,136

0.07

 

 

Further information required by the EU Market Abuse Regulation in relation to these transactions is set out in the appendix below.

 

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc

+ 44 20 7802 8080

8 January 2019

 

 

APPENDIX 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

James Michael Beale Cayzer-Colvin

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares arising from 1 and 2 above

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS awards

 

2. Call of DBP awards

 

3. Sale of shares

 

 

Price(s)

 

Volume(s)

£0.00

14,358

£0.00

 

10,670

 

£29.075

25,028

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

25,028 shares

 

Exercise of PSS awards/Call of DBP awards (£nil)

 

Sale of shares: £29.075

 

e)

 

Date of the transaction

 

8 January 2019

f)

 

Place of the transaction

 

 

Exercise of PSS and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

William Penfold Wyatt

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Caledonia Investments plc

b)

 

LEI

 

2138002FX1MYCA5ZZH32

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary 5p shares

 

 

GB0001639920

b)

 

Nature of the transaction

 

 

1. Exercise of Performance Share Scheme ("PSS") awards

2. Call of Deferred Bonus Plan ("DBP") awards

3. Sale of all shares arising from 1 and 2 above

 

 

c)

 

 

Price(s) and volume(s)

 

1. Exercise of PSS awards

 

2. Call of DBP awards

 

3. Sale of shares

 

 

Price(s)

 

Volume(s)

£0.00

 

23,352

 

£0.00

17,784

£29.075

41,136

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

41,136 shares

 

Exercise of PSS awards/Call of DBP awards (£nil)

 

Sale of shares: £29.075

 

e)

 

Date of the transaction

 

8 January 2019

f)

 

Place of the transaction

 

 

Exercise of PSS awards and call of DBP awards - outside a trading venue

Sale of shares - London Stock Exchange XLON

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSSAFIAFUSEDF
Date   Source Headline
8th Jan 201910:02 amRNSReport for the quarter ended 31 December 2018
8th Jan 201910:00 amRNSNet Asset Value(s)
2nd Jan 20198:31 amRNSBlock listing Interim Review
21st Dec 20189:04 amRNSAcquisition
19th Dec 201810:40 amRNSReclassification of AIC sector
19th Dec 20188:28 amRNSHalf-year Report
6th Dec 20189:47 amRNSNet Asset Value(s)
22nd Nov 20187:00 amRNSHalf-year Report
19th Nov 20182:45 pmRNSDirector Declaration
15th Nov 20187:00 amRNSDirectorate Change
7th Nov 20189:09 amRNSNet Asset Value(s)
23rd Oct 20187:48 amRNSDisposal
15th Oct 20187:00 amRNSAcquisition
4th Oct 20181:57 pmRNSNet Asset Value(s)
6th Sep 20189:41 amRNSNet Asset Value(s)
1st Aug 20181:43 pmRNSPortfolio Update
19th Jul 201812:52 pmRNSResult of AGM
16th Jul 201811:28 amRNSDirectorate Change
13th Jul 20187:49 amRNSAcquisition
6th Jul 201810:34 amRNSReport for the quarter ended 30 June 2018
6th Jul 201810:31 amRNSNet Asset Value(s)
2nd Jul 20188:35 amRNSBlock listing Interim Review
28th Jun 201811:34 amRNSHolding(s) in Company
19th Jun 20189:12 amRNSAnnual Financial Report
6th Jun 201812:47 pmRNSNet Asset Value(s)
31st May 20185:11 pmRNSTotal Voting Rights
31st May 20183:00 pmRNSDirector/PDMR Shareholding
31st May 20189:17 amRNSDirector/PDMR Shareholding
25th May 20185:02 pmRNSTransaction in Own Shares
24th May 20185:11 pmRNSFinal Results - Correction
24th May 20187:00 amRNSFinal Results
4th May 201810:31 amRNSNet Asset Value(s)
13th Apr 20184:31 pmRNSHolding(s) in Company
9th Apr 201811:51 amRNSNet Asset Value(s)
29th Mar 20183:33 pmRNSTransaction in Own Shares
6th Mar 201810:03 amRNSNet Asset Value(s)
15th Feb 20183:14 pmRNSDirector/PDMR Shareholding
6th Feb 20181:14 pmRNSNet Asset Value(s)
8th Jan 201812:31 pmRNSDirector/PDMR Shareholding
5th Jan 20181:24 pmRNSReport for the quarter ended 31 Dec 2017
5th Jan 20181:19 pmRNSNet Asset Value(s)
2nd Jan 20189:49 amRNSBlock listing Interim Review
20th Dec 201710:44 amRNSDirector/PDMR Shareholding
12th Dec 20178:57 amRNSHalf-year Report
6th Dec 201712:20 pmRNSNet Asset Value(s)
30th Nov 20175:29 pmRNSDirector/PDMR Shareholding
30th Nov 201711:39 amRNSDirectorate Change
23rd Nov 20177:00 amRNSHalf-year Report
6th Nov 20173:23 pmRNSNet Asset Value(s)
1st Nov 20179:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.